148 related articles for article (PubMed ID: 21448341)
1. Transgenic rice expressing amyloid β-peptide for oral immunization.
Yoshida T; Kimura E; Koike S; Nojima J; Futai E; Sasagawa N; Watanabe Y; Ishiura S
Int J Biol Sci; 2011 Mar; 7(3):301-7. PubMed ID: 21448341
[TBL] [Abstract][Full Text] [Related]
2. Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model.
Nojima J; Maeda A; Aoki S; Suo S; Yanagihara D; Watanabe Y; Yoshida T; Ishiura S
Vaccine; 2011 Aug; 29(37):6252-8. PubMed ID: 21726591
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-amyloid β antibodies in mice fed rice expressing amyloid β.
Nojima J; Ishii-Katsuno R; Futai E; Sasagawa N; Watanabe Y; Yoshida T; Ishiura S
Biosci Biotechnol Biochem; 2011; 75(2):396-400. PubMed ID: 21307566
[TBL] [Abstract][Full Text] [Related]
4. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
6. HSV amplicon-mediated Abeta vaccination in Tg2576 mice: differential antigen-specific immune responses.
Bowers WJ; Mastrangelo MA; Stanley HA; Casey AE; Milo LJ; Federoff HJ
Neurobiol Aging; 2005 Apr; 26(4):393-407. PubMed ID: 15653168
[TBL] [Abstract][Full Text] [Related]
7. Production of the herb Ruta chalepensis L. expressing amyloid β-GFP fusion protein.
Yoshida T; Watanabe Y; Ishiura S
Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(6):295-302. PubMed ID: 31189782
[TBL] [Abstract][Full Text] [Related]
8. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
9. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
10. Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.
Qu BX; Xiang Q; Li L; Johnston SA; Hynan LS; Rosenberg RN
J Neurol Sci; 2007 Sep; 260(1-2):204-13. PubMed ID: 17574274
[TBL] [Abstract][Full Text] [Related]
11. Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease.
Fu L; Li Y; Hu Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
Immunol Lett; 2015 Nov; 168(1):22-30. PubMed ID: 26349054
[TBL] [Abstract][Full Text] [Related]
12. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
[TBL] [Abstract][Full Text] [Related]
13. CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.
Obregon D; Hou H; Bai Y; Nikolic WV; Mori T; Luo D; Zeng J; Ehrhart J; Fernandez F; Morgan D; Giunta B; Town T; Tan J
Neurobiol Dis; 2008 Feb; 29(2):336-53. PubMed ID: 18055209
[TBL] [Abstract][Full Text] [Related]
14. Improved synaptic and cognitive function in aged 3 × Tg-AD mice with reduced amyloid-β after immunotherapy with a novel recombinant 6Aβ15-TF chimeric vaccine.
Yu YZ; Li QL; Wang HC; Liu S; Pang XB; Xu Q; Zhou XW; Huang PT
Clin Immunol; 2018 Aug; 193():12-23. PubMed ID: 29803820
[TBL] [Abstract][Full Text] [Related]
15. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
Nemirovsky A; Shapiro J; Baron R; Kompaniets A; Monsonego A
J Neuroimmunol; 2012 Jun; 247(1-2):95-9. PubMed ID: 22498096
[TBL] [Abstract][Full Text] [Related]
16. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
[TBL] [Abstract][Full Text] [Related]
17. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
Sigurdsson EM; Knudsen E; Asuni A; Fitzer-Attas C; Sage D; Quartermain D; Goni F; Frangione B; Wisniewski T
J Neurosci; 2004 Jul; 24(28):6277-82. PubMed ID: 15254082
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.
Petrushina I; Davtyan H; Hovakimyan A; Davtyan A; Passos GF; Cribbs DH; Ghochikyan A; Agadjanyan MG
Mol Ther; 2017 Jan; 25(1):153-164. PubMed ID: 28129111
[TBL] [Abstract][Full Text] [Related]
19. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
20. Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease.
Youm JW; Jeon JH; Kim H; Kim YH; Ko K; Joung H; Kim H
Biotechnol Lett; 2008 Oct; 30(10):1839-45. PubMed ID: 18604480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
